SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
IGM Biosciences, Inc. (IGMS) .
本页证实的标准:
- VALUE (90/100, 通过) — 分析师目标价暗示上行空间 (+37.8%).
- 分析师共识目标价 $1.75 (+37.8% 上行空间) — 华尔街分析师认为存在显著上行潜力。
SharesGrow 综合评分： 43/100 其中 2/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
90/100
Price-to-Earnings & upside
Proven by this page
✓
健康
75/100
Debt-to-Equity & liquidity
→ Health
估值概览 — IGMS
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率28.69
EV/EBITDA0.0
每股数据
EPS (TTM)$-3.24
每股账面价值$0.00
每股营收$0.04
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$1.75 (+37.8%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2017 |
$-25.24 |
$0.00 |
$-11.05M |
- |
| 2018 |
$-51.84 |
$0.00 |
$-22.71M |
- |
| 2019 |
$-4.73 |
$0.00 |
$-42.54M |
- |
| 2020 |
$-2.61 |
$0.00 |
$-80.33M |
- |
| 2021 |
$-4.80 |
$0.00 |
$-160.68M |
- |
| 2022 |
$-5.16 |
$1.07M |
$-214.25M |
-20041.9% |
| 2023 |
$-4.71 |
$2.13M |
$-246.42M |
-11568.8% |
| 2024 |
$-3.24 |
$2.68M |
$-195.8M |
-7308.5% |
